You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
Seizures after craniectomy: an under-recognised complication?
  1. R Loch Macdonald1,2
  1. 1Division of Neurosurgery, St. Michael=s Hospital, Labatt Family Centre of Excellence in Brain Injury and Trauma Research, Keenan Research Centre of the Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada
  2. 2Department of Surgery, University of Toronto, Toronto, Ontario, Canada
  1. Correspondence to Dr R Loch Macdonald, Division of Neurosurgery, St. Michael's Hospital, and Department of Surgery, University of Toronto, 30 Bond Street, Toronto, Toronto, ON, Canada M5B 1W8; macdonaldlo{at}smh.ca

https://doi.org/10.1136/jnnp-2013-306102

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Decompressive craniectomy for ischaemic stroke is being increasingly used, at least in the USA.1 This has likely been stimulated by three randomised clinical trials reporting improved survival in appropriately selected patients.2 As the number of patients so treated, and surviving, increases, a better picture of the complications and outcomes is emerging, with recognition of the relatively high risk of infection when the cranium is reconstructed after the craniectomy, as well as the occurrence of postoperative extra-axial haemorrhages and delayed hydrocephalus.3

    Creutzfeldt et al4 highlight another surprisingly frequent sequelae; seizures. They retrospectively review 55 patients who underwent decompressive craniectomy for middle cerebral artery territory infarction between 2002 and 2011. They found that 49% of patients had seizures and 45% developed epilepsy within a year of surgery. Seizures were more common in men. The seizures tended to occur soon after cranioplasty.

    Several aspects of this …

    View Full Text

    Footnotes

    • Competing interests RLM receives grant support from the Physicians Services Incorporated Foundation, Brain Aneurysm Foundation, Canadian Institutes for Health Research, and the Heart and Stroke Foundation of Canada; and is a consultant for Actelion Pharmaceuticals and the Chief Scientific Officer of Edge Therapeutics.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles